Table 1 Characteristics of the study population
Characteristics | Total (N = 632) | NAFLD (N = 176) | Normal (N = 456) | P |
|---|---|---|---|---|
Age, year | 64.81 (9.81) | 62.48 (10.51) | 65.71 (9.39) | < 0.01 |
Female, n (%) | 269 (42.56) | 69 (39.20) | 200 (43.86) | 0.29 |
BMI, kg/m2 | 24.26 (3.38) | 25.64 (3.69) | 23.73 (3.09) | < 0.01 |
Smoke, n (%) | 134 (21.20) | 34 (19.32) | 100 (21.32) | 0.47 |
Persistent AF, n (%) | 275 (43.51) | 76 (43.18) | 199 (43.64) | 0.92 |
SBP, mmHg | 128 (19) | 130 (19) | 126 (19) | 0.02 |
DBP, mmHg | 73 (14) | 77 (14) | 76 (14) | 0.81 |
Duration of AF, months | 34.31 (48.57) | 37.87 (56.42) | 32.94 (45.18) | 0.72 |
Laboratory results | ||||
AST, mmol/L | 23.52 (19.29–28.71) | 24.93 (20.10–30.38) | 23.19 (18.93–28.06) | 0.04 |
ALT, mmol/L | 20.04 (13.80–28.76) | 23.30 (17.01–33.76) | 18.73 (13.06–26.53) | < 0.01 |
TC, mmol/L | 4.24 (1.06) | 4.59 (1.18) | 4.10 (0.98) | < 0.01 |
TG, mmol/L | 1.23 (0.90–1.71) | 1.62 (1.11–2.38) | 1.14 (0.86–1.53) | < 0.01 |
HDL-C, mmol/L | 1.16 (0.31) | 1.08 (0.30) | 1.19 (0.32) | < 0.01 |
LDL-C, mmol/L | 2.49 (0.83) | 2.78 (0.95) | 2.38 (0.76) | < 0.01 |
Glucose, mmol/L | 5.13 (4.62–5.88) | 5.62 (4.88–6.89) | 5.02 (4.55–5.61) | < 0.01 |
HbA1C | 5.80 (5.50–6.10) | 5.90 (5.50–6.45) | 5.70 (5.40–6.00) | < 0.01 |
eGFR, mL/min/1.73m2 | 83.02 (21.65) | 85.75 (21.90) | 81.95 (21.48) | 0.05 |
UA, mmol/L | 377.33 (103.78) | 394.59 (104.08) | 370.62 (103.00) | < 0.01 |
HSI | 31.51 (4.89) | 33.80 (5.61) | 30.62 (4.26) | < 0.01 |
TyG index | 8.61 (0.62) | 9.00 (0.69) | 8.46 (0.53) | < 0.01 |
Chronic disease, n (%) | ||||
Hypertension | 359 (56.80) | 107 (60.80) | 252 (55.26) | 0.21 |
Diabetes | 133 (21.04) | 63 (35.80) | 70 (15.35) | < 0.01 |
Dyslipidemia | 267 (42.25) | 108 (61.36) | 159 (34.78) | < 0.01 |